文献速递前列腺增生与排尿功能障碍

选择性膀胱去神经术治疗女性难治性膀胱过度活动症的6个月结果

Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder.
PubMed 文献 · J Urol · 2019-01-01

两项前瞻性可行性研究纳入35例难治性膀胱过度活动症伴急迫性尿失禁女性,行选择性膀胱去神经术。6个月随访显示急迫性尿失禁和尿失禁症状改善59%(p<0.001),临床成功率70%,干/治愈率27%,6例(17%)报告器械或手术相关不良事件。

要点

  • 选择性膀胱去神经术在难治性OAB女性中6个月临床成功率达70%。
  • 急迫性尿失禁和尿失禁症状改善59%,干/治愈率27%。
  • 器械或手术相关不良事件报告率为17%(6例)。

核心结论

  • 两项前瞻性可行性研究的汇总结果提示,选择性膀胱去神经术是女性难治性OAB有前景的微创治疗选择。

研究设计与样本

  • 两项前瞻性可行性研究,纳入标准相同,共35例难治性OAB伴急迫性尿失禁女性,平均年龄66岁。
  • 患者接受包含传入感觉神经的膀胱三角下区域选择性去神经术,随访6个月。

主要发现

  • 基于3天膀胱日记,6个月时急迫性尿失禁改善59%(p<0.001),尿失禁改善59%(p<0.001)。
  • 急迫感改善39%(p<0.001),尿频改善9%(p=0.01),总急迫和频率评分改善27%(p<0.001)。
  • 大部分治疗获益在第一个月内实现。
  • 临床成功率(急迫性尿失禁减少≥50%)为70%,75%患者报告治疗获益,干/治愈率为27%。
  • OAB-q症状困扰和健康相关生活质量量表及KHQ除一般健康感知外的所有领域在6个月内均有统计学显著改善。

关键数值与推荐

  • 临床成功定义为急迫性尿失禁减少50%或以上,率为70%。
  • 干/治愈率为27%。
  • 器械或手术相关不良事件报告于6例患者(17%)。

临床怎么用

  • 对于难治性OAB女性,选择性膀胱去神经术可能作为微创治疗选择,需关注6个月内症状和生活质量改善。

局限性

  • 研究为两项前瞻性可行性研究的汇总分析,样本量较小(35例),随访仅6个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We report 6-month efficacy and safety outcomes of selective bladder denervation in women with refractory overactive bladder. MATERIALS AND METHODS: Women with refractory overactive bladder and urgency urinary incontinence were enrolled in 2 prospective feasibility studies with the same entry criteria. They underwent selective bladder denervation of the subtrigonal region containing afferent sensory nerves. Patients were followed for 6 months and assessed for adverse events, overactive bladder symptoms and health related quality of life measures. RESULTS: In the 35 women with a mean age of 66 years who were enrolled in the study all selective bladder denervation procedures were completed successfully. During 6 months of followup the symptom improvement based on 3-day bladder diaries was 59% for urgency urinary incontinence (p <0.001), 59% for urinary incontinence (p <0.001), 39% for urgency (p <0.001), 9% for urinary frequency (p = 0.01) and 27% for the total urgency and frequency score (p <0.001). Most of this treatment benefit was realized in the first month. The rate of clinical success, defined as a 50% or greater reduction in urgency urinary incontinence, was 70%, treatment benefit was reported in 75% of patients and the dry/cure rate was 27%. Statistically significant improvements during 6 months were identified on the symptom bother and health related quality of life scales on the OAB-q (Overactive Bladder Questionnaire) and on all KHQ (King's Health Questionnaire) domains except general health perception. Device or procedure related adverse events were reported in 6 patients (17%). CONCLUSIONS: Pooled results of 2 prospective feasibility studies suggest that selective bladder denervation is a promising minimally invasive treatment option in women with refractory overactive bladder.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. De Wachter S, Benson KD, Dmochowski RR, et al. Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder. J Urol. 2019. PMID: 30240691. doi:10.1016/j.juro.2018.09.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。